Equity Capital Markets and Advisory Business, Auctus Advisors

Auctus Advisors

Equity Capital Markets and Advisory Business

Auctus Advisors is a specialist Equity Capital Markets and Advisory business with a focus in the Energy Sector. The partners have complementary skill sets, with decades of experience across Equity Capital Markets, Investment Banking and the Energy industry. We have worked at Société Générale, Canaccord Capital, BMO Capital Markets and Schlumberger. Most recently we have worked together for many years at GMP FirstEnergy. Auctus has been set up at the beginning of a new decade in which we see significant opportunities in the Energy space. Globally, demand for energy is at record levels and continues to grow. Conversely, investment in traditional energy sources has been severely constrained. We believe this imbalance creates opportunities for both companies and investors. Auctus provides Corporate Broking, Equity Research and Investment Banking services.

Equity Bottom-Up

<ul><li>Positive testing results opens the Montney - Calima has so far obtained very good results from the re-testing of the Calima #2 and Calima #3 wells.</li><li>This could de-risk the initial development of the Montney with potential for production in 2024.</li><li>This could also materially increase the likelihood of attracting an industry partner. </li></ul>

Positive testing results opens the Montney - Calima has so far obtained very good results from the re-testing of the Calima #2 and Calima #3 wells.This could de-risk the initial development of the Montney with potential for production in 2024.This could also materially increase the likelihood of attracting an industry partner. 

<ul><li><strong>GeoPark (GPRK US)C: Target price of US$31 per share:</strong><strong>Two new strong development wells at CPO-5</strong> – Two new development wells, Indico 6 and Indico 7, tested over 11,000 bbl/d gross (in aggregate) with hardly any water (Indico 6: 6,270 bbl/d, Indico 7: 5,245 bbl/d).</li><li>This would take gross production from the field from ~20 mbbl/d in 4Q22 to 25-27 mbbl/d.</li><li>OKEA Energy (OKEA NO): 4Q22 update – 4Q22 production in Norway was 19,887 boe/d.</li></ul>

GeoPark (GPRK US)C: Target price of US$31 per share:Two new strong development wells at CPO-5 – Two new development wells, Indico 6 and Indico 7, tested over 11,000 bbl/d gross (in aggregate) with hardly any water (Indico 6: 6,270 bbl/d, Indico 7: 5,245 bbl/d).This would take gross production from the field from ~20 mbbl/d in 4Q22 to 25-27 mbbl/d.OKEA Energy (OKEA NO): 4Q22 update – 4Q22 production in Norway was 19,887 boe/d.

European Event-Driven Analyst

Jesus Rodriguez Aguilar

Event-Driven

<ul>
<li>The NewMed/Capricorn reverse takeover should be approved at an EGM. Investors opposing the deal (mainly event-driven funds) hold in aggregate at least c. 33.6% of cash-rich Capricorn. </li>
<li>The approval threshold is 50% (vs. 75% in Tullow's merger), which should favour the approval. But the +6.9% spread (as of 28 November), reveals it'll be challenging.</li>
<li>First Tullow sought CNE's cash pile, now NewMed seeks CNE's Middle East assets and a coveted London listing. Unless NewMed sweetens the terms, this deal may not happen either.</li>
</ul>


The NewMed/Capricorn reverse takeover should be approved at an EGM. Investors opposing the deal (mainly event-driven funds) hold in aggregate at least c. 33.6% of cash-rich Capricorn. 
The approval threshold is 50% (vs. 75% in Tullow's merger), which should favour the approval. But the +6.9% spread (as of 28 November), reveals it'll be challenging.
First Tullow sought CNE's cash pile, now NewMed seeks CNE's Middle East assets and a coveted London listing. Unless NewMed sweetens the terms, this deal may not happen either.


NewMed Energy/​Capricorn: Positive Spread

<ul>
<li>Capricorn Energy withdrew the recommendation to merge with Tullow to instead merge with NewMed Energy LP thorugh a reverse takeover  to create one of the largest European E&amp;P companies.</li>
<li>Capricorn shareholders will receive an upfront dividend and a residual interest in a MENA gas champion (which, unlike Tullow, does not need Capricorn's large cash balance to develop fields).</li>
<li>The deal offers certainty for Capricorn's shareholders. Chances to complete are high. Gross spread is 5.8%. Long Capricorn or setting up the spread (but NewMed is not massively liquid).</li>
</ul>


Capricorn Energy withdrew the recommendation to merge with Tullow to instead merge with NewMed Energy LP thorugh a reverse takeover  to create one of the largest European E&amp;P companies.
Capricorn shareholders will receive an upfront dividend and a residual interest in a MENA gas champion (which, unlike Tullow, does not need Capricorn's large cash balance to develop fields).
The deal offers certainty for Capricorn's shareholders. Chances to complete are high. Gross spread is 5.8%. Long Capricorn or setting up the spread (but NewMed is not massively liquid).


NewMed Energy/Capricorn: Agreed Reverse Takeover, Bye Bye Tullow

<ul>
<li>On 9 September, Capricorn's closing share price was at a c. 29% premium vs. merger terms (186.46p); scheme approval seems tricky. Capricorn has signaled it is open to explore other transactions.</li>
<li>To rebalance the exchange equation, Tullow should offer at least 4.904043 TLW LN x 1 CNE LN, which would change the balance of power (Capricorn 51.8%, Tullow 48.2%).</li>
<li>Cash makes up to 72% of Capricorn's shares, whose latest price movements could either anticipate some statement from Tullow or other "potential outcomes". I'd be long Capricorn, rather than the spread.</li>
</ul>


On 9 September, Capricorn's closing share price was at a c. 29% premium vs. merger terms (186.46p); scheme approval seems tricky. Capricorn has signaled it is open to explore other transactions.
To rebalance the exchange equation, Tullow should offer at least 4.904043 TLW LN x 1 CNE LN, which would change the balance of power (Capricorn 51.8%, Tullow 48.2%).
Cash makes up to 72% of Capricorn's shares, whose latest price movements could either anticipate some statement from Tullow or other "potential outcomes". I'd be long Capricorn, rather than the spread.


Tullow/Capricorn: Unsuitable on Current Terms

United Kingdom

Capricorn Energy PLC is oil and gas exploration and development company. The Company operates in North West Europe, North Atlantic, Mediterranean, and South Asia.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Capricorn Energy (CNE LN)

Auctus on Friday - 17/02/2023

Positive testing results opens the Montney - Calima has so far obtained very good results from the re-testing of the Calima #2 and Calima #3 wells.

Auctus Advisors

Auctus on Friday - 27/02/2023

Two new development wells, Indico 6 and Indico 7, tested over 11,000 bbl/d gross (in aggregate) with hardly any water (Indico 6: 6,270 bbl/d,...

Auctus Advisors

NewMed Energy/Capricorn: Positive Spread

Althugh the terms were greatly improved vs. the failed Tullow berger, top shareholders have spoken out against the sale to NewMed and argue that...

Jesus Rodriguez Aguilar

NewMed Energy/Capricorn: Agreed Reverse Takeover, Bye Bye Tullow

With the announcement of the combination with Tullow, Capricorn put itself up for sale. The deal with NewMed provides arguably more security to...

Jesus Rodriguez Aguilar

Tullow/Capricorn: Unsuitable on Current Terms

On Friday 9 September, the closing share price of Capricorn was 240.2p, a c. 29% premium vs. the exchange equation (186.46p). The Board of...

Jesus Rodriguez Aguilar

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

Auctus on Friday - 17/02/2023

Positive testing results opens the Montney - Calima has so far obtained very good results from the re-testing of the Calima #2 and Calima #3 wells.

Auctus Advisors

Auctus on Friday - 27/02/2023

Two new development wells, Indico 6 and Indico 7, tested over 11,000 bbl/d gross (in aggregate) with hardly any water (Indico 6: 6,270 bbl/d,...

Auctus Advisors

NewMed Energy/​Capricorn: Positive Spread

Althugh the terms were greatly improved vs. the failed Tullow berger, top shareholders have spoken out against the sale to NewMed and argue that...

Jesus Rodriguez Aguilar

NewMed Energy/Capricorn: Agreed Reverse Takeover, Bye Bye Tullow

With the announcement of the combination with Tullow, Capricorn put itself up for sale. The deal with NewMed provides arguably more security to...

Jesus Rodriguez Aguilar

Tullow/Capricorn: Unsuitable on Current Terms

On Friday 9 September, the closing share price of Capricorn was 240.2p, a c. 29% premium vs. the exchange equation (186.46p). The Board of...

Jesus Rodriguez Aguilar

NewMed Energy/Capricorn: Positive Spread